Literature DB >> 12410704

An immunohistochemical and ultrastructural study of syringocystadenoma papilliferum.

O Yamamoto1, Y Doi, T Hamada, M Hisaoka, Y Sasaguri.   

Abstract

BACKGROUND: Syringocystadenoma papilliferum is a benign hamartomatous tumour of the skin. The histogenesis of this tumour is still controversial. There have been few reports regarding immunohistochemical investigations using only a limited range of antibodies and ultrastructural studies on this rare tumour.
OBJECTIVES: To elucidate the immunohistochemical and ultrastructural properties of this tumour.
METHODS: We investigated the immunohistological patterns of 12 different anticytokeratin (CK) antibodies and several other markers in five cases of this tumour, comparing them with the patterns in adult sweat glands. One of these cases was also evaluated ultrastructurally.
RESULTS: The luminal columnar cells of the tumour were mostly positive for CK7 and more than 70% were positive for CK19. These cells showed the heterogeneous expression of CK1/5/10/14, CK14 and CK5/8. These patterns were also observed in the luminal cells in the secretory or the ductal portion of the adult sweat glands. The basal cuboidal cells of the tumour almost constantly expressed CK1/5/10/14, CK5/8, CK14 and CK7 (except for one case), similar to the patterns of basal cells in the transitional portion and myoepithelial cells in the sweat glands. However, the basal tumour cells expressed CK19 and vimentin heterogeneously, and alpha-smooth muscle actin focally (three cases). Ultrastructurally, the constituent epithelial cells were mainly divided into three types: luminal cells, basal cells and clear cells. The luminal tumour cells bore features of the secretory or ductal luminal cells of sweat glands, although they were somewhat immature in appearance. The basal tumour cells were fundamentally basaloid in nature. The clear cells were undifferentiated or primitive in appearance, suggesting stem or progenitor cell properties. Transitional forms between the clear cells and the other two cell types were also identified.
CONCLUSIONS: The tumour epithelium was composed of several cell types demonstrating various developmental stages from the primitive clear cells to the basal cells demonstrating a tendency to differentiate toward basal cells in the apocrine transitional portion or myoepithelial lineage, or luminal cells toward the ductal or secretory epithelium. These results support the classical concept that syringocystadenoma papilliferum is a hamartomatous tumour that arises from pluripotent cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12410704     DOI: 10.1046/j.1365-2133.2002.05027.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  10 in total

1.  Syringocystadenoma papilliferum of the upper lip.

Authors:  Hamdan A Al-Habsi; Mustafa Al-Hinai; Ahmed Al-Waily; Salim Al-Sudairy; Vipula de Silva
Journal:  Sultan Qaboos Univ Med J       Date:  2014-10-14

Review 2.  Skin adnexal neoplasms--part 2: an approach to tumours of cutaneous sweat glands.

Authors:  Nidal A Obaidat; Khaled O Alsaad; Danny Ghazarian
Journal:  J Clin Pathol       Date:  2006-08-01       Impact factor: 3.411

3.  Linear syringocystadenoma papilliferum: a case report with review of literature.

Authors:  Amrita Chauhan; Lipy Gupta; Ram Krishan Gautam; Minakshi Bhardwaj; Kiran Gopichandani
Journal:  Indian J Dermatol       Date:  2013-09       Impact factor: 1.494

4.  A case of syringocystadenoma papilliferum on lower leg: a rare location.

Authors:  Vinod K Khurana; Raj K Mehta; Deepak Chaudhary; Leela Pant
Journal:  Indian J Dermatol       Date:  2013-09       Impact factor: 1.494

Review 5.  Somatic V600E BRAF Mutation in Linear and Sporadic Syringocystadenoma Papilliferum.

Authors:  Jonathan L Levinsohn; Jeffrey L Sugarman; Kaya Bilguvar; Jennifer M McNiff; Keith A Choate
Journal:  J Invest Dermatol       Date:  2015-05-07       Impact factor: 8.551

6.  A new case of syringocystadenocarcinoma papilliferum: a rare pathology for a wide-ranging comprehension.

Authors:  Beatrice Paradiso; Enzo Bianchini; Pierangelo Cifelli; Luigi Cavazzini; Giovanni Lanza
Journal:  Case Rep Med       Date:  2014-05-15

7.  Mutant Lef1 controls Gata6 in sebaceous gland development and cancer.

Authors:  Bénédicte Oulès; Emanuel Rognoni; Esther Hoste; Georgina Goss; Ryan Fiehler; Ken Natsuga; Sven Quist; Remco Mentink; Giacomo Donati; Fiona M Watt
Journal:  EMBO J       Date:  2019-03-18       Impact factor: 11.598

Review 8.  Current Diagnosis and Treatment Options for Cutaneous Adnexal Neoplasms with Apocrine and Eccrine Differentiation.

Authors:  Iga Płachta; Marcin Kleibert; Anna M Czarnecka; Mateusz Spałek; Anna Szumera-Ciećkiewicz; Piotr Rutkowski
Journal:  Int J Mol Sci       Date:  2021-05-11       Impact factor: 5.923

9.  Neonatal syringocystadenoma papilliferum: A case report.

Authors:  Hong-Jing Jiang; Zhao Zhang; Li Zhang; Yun-Jing Pu; Nian Zhou; Hong Shu
Journal:  World J Clin Cases       Date:  2021-06-26       Impact factor: 1.337

10.  Syringocystadenoma papilliferum in the right lower abdomen: a case report and review of literature.

Authors:  Dong Xu; Tienan Bi; Huanrong Lan; Wenjie Yu; Wenmin Wang; Feilin Cao; Ketao Jin
Journal:  Onco Targets Ther       Date:  2013-03-26       Impact factor: 4.147

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.